| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |